BACKGROUND: Public health interventions that prevent mortality and morbidity have greatly
increased over the past decade. Immunization is one of these preventive interventions, with …

Background Most health economic evaluations of childhood vaccination only capture the
health and short-term economic benefits. Measuring broader, long-term effects of …

Objectives To update cost effectiveness estimates for the four dose (3+ 1) schedule of the
seven valent pneumococcal conjugated vaccine (PCV-7) in the Netherlands and to explore …

Pneumococcal disease (PD) is the leading cause of vaccine preventable deaths in children<
5 years of age worldwide, with most of the deaths occurring in the developing world …

Background Pneumococcal diseases cause substantial mortality, morbidity, and economic
burden. Evidence on data inputs for economic evaluations of interventions targeting …

ResumoFoi realizada uma revisão sistemática com o objetivo de descrever o panorama e a
evolução de estudos de custo-efetividade em saúde no Brasil. A busca de artigos sobre …

Objective Since the 10-valent pneumococcal conjugate vaccine (PCV-10) and 13-valent
pneumococcal conjugate vaccine (PCV-13) were recently licensed for use in Argentina, both …

Background Seven-valent pneumococcal conjugate vaccines (PCV7) have been used in
children for more than a decade. Given the observed increase in disease caused by …

Objective The objectives of this review were to identify vaccine economic evaluations that
include herd immunity and describe the methodological approaches used. Methods We …

The COVID-19 pandemic has profoundly impacted individuals, resulting in long-lasting
consequences. One of the effects has been a decline in vaccine adherence attributed to …